Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - STOCK-BASED COMPENSATION
Stock-based Compensation DMAC - DiaMedica Therapeutics Inc.
1.68 M
LAST VALUE
3.93%
2 YEAR CAGR
22.11%
5 YEAR CAGR
9.10%
10 YEAR CAGR